Clin2
NCT07511413Likely a fitRecruiting

Monitoring health in head, neck, lung & rectal cancer

Head and Neck Squamous Cell CarcinomaLocally Advanced Rectal CancerLung Cancer

Part of Brain & nervous system, Cancer, Lungs & breathing clinical trials.

This trial is studying how a monitoring method (bioimpedance) works for people with head and neck, lung, or rectal cancer who are about to start standard treatment. It may help doctors track your health better during therapy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
110 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have head and neck, lung, or rectal cancer that is confirmed by a biopsy.
  • You are a candidate for standard cancer therapy (like chemotherapy, radiation, or immunotherapy).
  • You are 18 years or older and able to be up and about for at least half of the day.
  • Your kidneys, liver, and blood counts are working well enough (tests will check).
  • You do not have another active cancer (except some very early skin cancers) or an infection needing IV antibiotics.
  • You do not have severe fluid buildup (edema or ascites) that would affect body weight checks.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07514754Recruiting
Immunonutrition support during cancer treatment

This study tests whether special nutritional support (called immunonutrition) helps patients with head and neck, lung, or rectal cancer who are receiving chemotherapy, radiation, or immunotherapy. The goal is to see if it improves how well treatment works and how you feel during and after cancer care.

Candiolo, Torino (TO)
NCT06410300Recruiting
Heart and lung monitoring during lung cancer radiation and immunotherapy

This study monitors how the heart and lungs respond to radiation therapy combined with immunotherapy for locally advanced lung cancer. It aims to learn how well patients tolerate treatment and to detect early signs of side effects.

Columbia, Missouri
NCT06163534Recruiting
Biomarker profiling study for advanced head and neck cancer patients

This study collects blood and tumor tissue samples to analyze biological markers in patients with advanced head and neck squamous cell carcinoma before starting immunotherapy. The goal is to better understand how these markers relate to treatment response.

Duarte, California
NCT07190755Recruiting
Symptom tracking with a smartphone app for head and neck cancer

This trial uses a smartphone app to track your symptoms during radiation treatment for head and neck cancer. It aims to help your care team catch problems early and improve your quality of life.

Rouen
NCT06252142Recruiting
Monitoring after rectal cancer treatment

This study looks at whether careful monitoring (watch and wait) is a good option for people with rectal cancer who have already had certain treatments. It aims to see if this approach can help avoid major surgery.

Mumbai, Maharashtra
NCT06597240Recruiting
Home monitoring during chemoradiation for esophageal cancer

This study tests whether monitoring your health at home during chemoradiation for esophageal cancer can improve care and outcomes. You'll measure things like temperature and symptoms, and share them with your care team.

Groningen

Hear when a new Head and Neck Squamous Cell Carcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.